Saar Gill, MD: Combining CAR T-Cell Therapy With Ibrutinib in CLL Patients
1 Lượt xem
administrator
07/14/23
Adding ibrutinib to treatment with CAR T-cell therapy was feasible, led to deeper remissions, and reduced the severity of cytokine release syndrome in patients with chronic lymphocytic leukemia.
Cho xem nhiều hơn
Bình luận trên Facebook
Không có bình luận nào được tìm thấy